News

share

US-based private equity firm Egyptian American Enterprise Fund (EAEF) has acquired 46.5% stake in Egyptian ophthalmic pharmaceutical products...

share

Sanofi has signed a licence agreement to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246), which is...

4 shares

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines....

share

Quotient Clinical announced that it has signed an agreement with Nuformix Technologies Limited (a wholly owned subsidiary of...

share

Impel NeuroPharma announced that the first patient was dosed in the recently-initiated Phase 1 clinical trial of INP104...

share

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from...

share

Otsuka Pharmaceutical and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials...

share

Merck announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance viral and gene therapy products has completed...